These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 31961896)

  • 1. Neuromuscular blockers in the acute respiratory distress syndrome: A meta-analysis.
    Hua Y; Ou X; Li Q; Zhu T
    PLoS One; 2020; 15(1):e0227664. PubMed ID: 31961896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromuscular blocking agents for acute respiratory distress syndrome: an updated meta-analysis of randomized controlled trials.
    Zheng Z; Jiang L; Zhang S; Guervilly C; Zhang M; Feng X; Ding J
    Respir Res; 2020 Jan; 21(1):23. PubMed ID: 31931794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early neuromuscular blocking agents for adults with acute respiratory distress syndrome: a systematic review, meta-analysis and meta-regression.
    Shao S; Kang H; Tong Z
    BMJ Open; 2020 Nov; 10(11):e037737. PubMed ID: 33444180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of neuromuscular blocking agent use in acute respiratory distress syndrome: a meta-analysis of randomized trials.
    Chang W; Sun Q; Peng F; Xie J; Qiu H; Yang Y
    Crit Care; 2020 Feb; 24(1):54. PubMed ID: 32066488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromuscular blocking agents for adult patients with acute respiratory distress syndrome: A meta-analysis of randomized controlled trials.
    Tao W; Yang LQ; Gao J; Shao J
    J Trauma Acute Care Surg; 2018 Dec; 85(6):1102-1109. PubMed ID: 30462621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of neuromuscular blocking agents uses in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Lyu T; Lee YS; Dhanvijay S; Freebairn R
    Minerva Anestesiol; 2021 Mar; 87(3):341-350. PubMed ID: 33300324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Best evidence in critical care medicine: The role of neuromuscular blocking drugs in early severe acute respiratory distress syndrome.
    Needham CJ; Brindley PG
    Can J Anaesth; 2012 Jan; 59(1):105-8. PubMed ID: 22042702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of neuromuscular blockers in ARDS: benefits and risks.
    Hraiech S; Forel JM; Papazian L
    Curr Opin Crit Care; 2012 Oct; 18(5):495-502. PubMed ID: 22941207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromuscular blockers in early acute respiratory distress syndrome.
    Papazian L; Forel JM; Gacouin A; Penot-Ragon C; Perrin G; Loundou A; Jaber S; Arnal JM; Perez D; Seghboyan JM; Constantin JM; Courant P; Lefrant JY; Guérin C; Prat G; Morange S; Roch A;
    N Engl J Med; 2010 Sep; 363(12):1107-16. PubMed ID: 20843245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A meta-analysis of the effect of neuromuscular blocking agents on oxygenation in patients with acute respiratory distress syndrome].
    Gao ZW; Li C; Chen H; Xie JF; Liu L; Yang Y
    Zhonghua Nei Ke Za Zhi; 2022 Jan; 61(1):86-94. PubMed ID: 34979776
    [No Abstract]   [Full Text] [Related]  

  • 11. Higher PEEP improves outcomes in ARDS patients with clinically objective positive oxygenation response to PEEP: a systematic review and meta-analysis.
    Guo L; Xie J; Huang Y; Pan C; Yang Y; Qiu H; Liu L
    BMC Anesthesiol; 2018 Nov; 18(1):172. PubMed ID: 30447683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromuscular Blocking Agents for ARDS: A Systematic Review and Meta-Analysis.
    Torbic H; Krishnan S; Harnegie MP; Duggal A
    Respir Care; 2021 Jan; 66(1):120-128. PubMed ID: 32843506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromuscular blockade in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Ho ATN; Patolia S; Guervilly C
    J Intensive Care; 2020; 8():12. PubMed ID: 32015880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of neuromuscular blocking agents on prognosis of patients with acute respiratory distress syndrome: a meta analysis].
    Wang AT; Gao JL; Li XL; Leng YX; Yao ZY; Zhu X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Mar; 25(3):149-53. PubMed ID: 23656767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. To Block or Not: Updates in Neuromuscular Blockade in Acute Respiratory Distress Syndrome.
    Mefford B; Donaldson JC; Bissell BD
    Ann Pharmacother; 2020 Sep; 54(9):899-906. PubMed ID: 32111121
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Alhazzani W; Alshahrani M; Jaeschke R; Forel JM; Papazian L; Sevransky J; Meade MO
    Crit Care; 2013 Mar; 17(2):R43. PubMed ID: 23497608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of surfactant administration on outcomes of adult patients in acute respiratory distress syndrome: a meta-analysis of randomized controlled trials.
    Meng SS; Chang W; Lu ZH; Xie JF; Qiu HB; Yang Y; Guo FM
    BMC Pulm Med; 2019 Jan; 19(1):9. PubMed ID: 30626363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromuscular blocking agents in acute respiratory distress syndrome: updated systematic review and meta-analysis of randomized trials.
    Tarazan N; Alshehri M; Sharif S; Al Duhailib Z; Møller MH; Belley-Cote E; Alshahrani M; Centofanti J; McIntyre L; Baw B; Meade M; Alhazzani W;
    Intensive Care Med Exp; 2020 Oct; 8(1):61. PubMed ID: 33095344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paediatric Acute Respiratory Distress Syndrome Neuromuscular Blockade study (PAN-study): a phase IV randomised controlled trial of early neuromuscular blockade in moderate-to-severe paediatric acute respiratory distress syndrome.
    Rudolph MW; Slager S; Burgerhof JGM; van Woensel JBM; Alffenaar JC; Wösten-van Asperen RM; de Hoog M; IJland MM; Kneyber MCJ;
    Trials; 2022 Jan; 23(1):96. PubMed ID: 35101098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-frequency ventilation versus conventional ventilation for treatment of acute lung injury and acute respiratory distress syndrome.
    Sud S; Sud M; Friedrich JO; Wunsch H; Meade MO; Ferguson ND; Adhikari NK
    Cochrane Database Syst Rev; 2013 Feb; (2):CD004085. PubMed ID: 23450549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.